409 related articles for article (PubMed ID: 31759100)
1. Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway.
Lu Q; Liu J; Li X; Sun X; Zhang J; Ren D; Tong N; Li J
Mol Cell Endocrinol; 2020 Feb; 501():110642. PubMed ID: 31759100
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway.
Hu H; Li X; Ren D; Tan Y; Chen J; Yang L; Chen R; Li J; Zhu P
Biomed Pharmacother; 2019 Sep; 117():109106. PubMed ID: 31200253
[TBL] [Abstract][Full Text] [Related]
3. Dichloroacetate Ameliorates Cardiac Dysfunction Caused by Ischemic Insults Through AMPK Signal Pathway-Not Only Shifts Metabolism.
Li X; Liu J; Hu H; Lu S; Lu Q; Quan N; Rousselle T; Patel MS; Li J
Toxicol Sci; 2019 Feb; 167(2):604-617. PubMed ID: 30371859
[TBL] [Abstract][Full Text] [Related]
4. Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
Uthman L; Nederlof R; Eerbeek O; Baartscheer A; Schumacher C; Buchholtz N; Hollmann MW; Coronel R; Weber NC; Zuurbier CJ
Cardiovasc Res; 2019 Aug; 115(10):1533-1545. PubMed ID: 30649212
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway.
Yang H; Sun W; Quan N; Wang L; Chu D; Cates C; Liu Q; Zheng Y; Li J
Biochem Pharmacol; 2016 May; 108():47-57. PubMed ID: 27015742
[TBL] [Abstract][Full Text] [Related]
7. Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress.
Nikolaou PE; Efentakis P; Abu Qourah F; Femminò S; Makridakis M; Kanaki Z; Varela A; Tsoumani M; Davos CH; Dimitriou CA; Tasouli A; Dimitriadis G; Kostomitsopoulos N; Zuurbier CJ; Vlahou A; Klinakis A; Brizzi MF; Iliodromitis EK; Andreadou I
Antioxid Redox Signal; 2021 Mar; 34(7):551-571. PubMed ID: 32295413
[No Abstract] [Full Text] [Related]
8. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
Wang L; Quan N; Sun W; Chen X; Cates C; Rousselle T; Zhou X; Zhao X; Li J
Cardiovasc Res; 2018 May; 114(6):805-821. PubMed ID: 29409011
[TBL] [Abstract][Full Text] [Related]
9. Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart.
Morrison A; Chen L; Wang J; Zhang M; Yang H; Ma Y; Budanov A; Lee JH; Karin M; Li J
FASEB J; 2015 Feb; 29(2):408-17. PubMed ID: 25366347
[TBL] [Abstract][Full Text] [Related]
10. ATPase inhibitory factor 1 protects the heart from acute myocardial ischemia/reperfusion injury through activating AMPK signaling pathway.
Wu JW; Hu H; Hua JS; Ma LK
Int J Biol Sci; 2022; 18(2):731-741. PubMed ID: 35002521
[No Abstract] [Full Text] [Related]
11. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts.
Li Q; Li N; Cui HH; Tian XQ; Jin C; Chen GH; Yang YJ
Exp Physiol; 2017 Apr; 102(4):422-435. PubMed ID: 28150462
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats.
Seefeldt JM; Lassen TR; Hjortbak MV; Jespersen NR; Kvist F; Hansen J; Bøtker HE
Sci Rep; 2021 May; 11(1):9544. PubMed ID: 33953281
[TBL] [Abstract][Full Text] [Related]
13. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
Liu X; Xu C; Xu L; Li X; Sun H; Xue M; Li T; Yu X; Sun B; Chen L
Metabolism; 2020 Oct; 111():154334. PubMed ID: 32777444
[TBL] [Abstract][Full Text] [Related]
14. AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis.
Kosuru R; Cai Y; Kandula V; Yan D; Wang C; Zheng H; Li Y; Irwin MG; Singh S; Xia Z
Cell Physiol Biochem; 2018; 46(4):1381-1397. PubMed ID: 29689567
[TBL] [Abstract][Full Text] [Related]
15. Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death.
Hu Z; Ju F; Du L; Abbott GW
Cardiovasc Diabetol; 2021 Oct; 20(1):199. PubMed ID: 34607570
[TBL] [Abstract][Full Text] [Related]
16. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury.
Kim AS; Miller EJ; Wright TM; Li J; Qi D; Atsina K; Zaha V; Sakamoto K; Young LH
J Mol Cell Cardiol; 2011 Jul; 51(1):24-32. PubMed ID: 21402077
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway.
Yao M; Wang Z; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zeng W; Yang W; Liang R; Qian J
Biomed Pharmacother; 2022 Sep; 153():113498. PubMed ID: 36076588
[TBL] [Abstract][Full Text] [Related]
18. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
19. The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy.
Huang L; Dai K; Chen M; Zhou W; Wang X; Chen J; Zhou W
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):70-81. PubMed ID: 25868658
[TBL] [Abstract][Full Text] [Related]
20. Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside pretreatment attenuates myocardial ischemia/reperfusion injury via activating AMPK signaling.
Feng Y; Lu Y; Liu D; Zhang W; Liu J; Tang H; Zhu Y
Life Sci; 2018 Jun; 203():246-254. PubMed ID: 29705352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
